HCW Biologics (HCWB) Common Equity (2020 - 2025)
HCW Biologics' (HCWB) quarterly Common Equity came in at $2.8 million in Q4 2025, up 140.84% YoY from $1.1 million in Q4 2024, and up 231.21% on a QoQ basis from -$2.1 million in Q3 2025.
HCW Biologics (HCWB) Common Equity (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Common Equity data on file, last reported at $2.8 million in Q4 2025.
- Quarterly Common Equity rose 140.84% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 140.84% YoY) and the FY2025 annual result came in at $2.8 million, up 140.84% from the prior year.
- Common Equity rose to $2.8 million in Q4 2025, from -$2.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $54.0 million in Q3 2021 to a low of -$23.2 million in Q2 2021.
- A 5-year average of $15.7 million and a median of $11.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity surged 406.21% — and 2025, when it slumped 197.96%.
- Tracing HCWB's Common Equity over 5 years: stood at $51.2 million in 2021, then slipped by 26.89% to $37.4 million in 2022, then tumbled by 64.03% to $13.5 million in 2023, then plunged by 150.29% to -$6.8 million in 2024, then soared by 140.84% to $2.8 million in 2025.
- The last three Common Equity figures came in at $2.8 million (Q4 2025), -$2.1 million (Q3 2025), and -$51972.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | -2.11 Mn |
| Jun 30, 2025 | -51,972.00 |
| Mar 31, 2025 | -8.56 Mn |
| Dec 31, 2024 | -6.77 Mn |
| Sep 30, 2024 | -9.97 Mn |
| Jun 30, 2024 | -6.30 Mn |
| Mar 31, 2024 | 8.74 Mn |
| Dec 31, 2023 | 13.46 Mn |
| Sep 30, 2023 | 23.87 Mn |
| Jun 30, 2023 | 28.59 Mn |
| Mar 31, 2023 | 32.62 Mn |
| Dec 31, 2022 | 37.43 Mn |
| Sep 30, 2022 | 42.56 Mn |
| Jun 30, 2022 | 46.17 Mn |
| Mar 31, 2022 | 49.40 Mn |
| Dec 31, 2021 | 51.19 Mn |
| Sep 30, 2021 | 54.01 Mn |
| Jun 30, 2021 | -23.24 Mn |
| Mar 31, 2021 | -20.03 Mn |